OPKO Health Inc (OPK.N)

OPK.N on New York Stock Exchange

6.94USD
21 May 2013
Price Change (% chg)

$-0.06 (-0.86%)
Prev Close
$7.00
Open
$7.05
Day's High
$7.11
Day's Low
$6.92
Volume
242,366
Avg. Vol
351,293
52-wk High
$7.83
52-wk Low
$4.01

OPK.N

Chart for OPK.N

About

OPKO Health, Inc. (OPKO), incorporated in October 1991, is a multi-national pharmaceutical and diagnostics company. OPKO is developing a range of solutions to diagnose, treat and prevent various conditions, including molecular diagnostics tests, point-of-care tests, and pharmaceuticals and vaccines. Its pharmaceutical segment... (more)

Overall

Beta: 1.23
Market Cap (Mil.): $2,357.16
Shares Outstanding (Mil.): 336.74
Dividend: --
Yield (%): --

Financials

  OPK.N Industry Sector
P/E (TTM): -- 35.67 35.85
EPS (TTM): -0.19 -- --
ROI: -12.61 19.40 18.76
ROE: -23.90 20.11 19.57
Search Stocks

Latest News about OPK.N

OPKO Health to buy Israel's Prolor Biotech for $480 million

TEL AVIV - OPKO Health Inc will buy Israel-based biopharmaceutical company Prolor Biotech Inc in an all-stock deal valued at $480 million to expand its portfolio of specialty drugs.

24 Apr 2013

OPKO Health to buy Biotech company Prolor for $480 million

April 24 - OPKO Health Inc said it would buy biopharmaceutical company Prolor Biotech Inc in an all-stock deal to expand its portfolio of specialty drugs.

24 Apr 2013
» More OPK.N News

Competitors

  Price Change
Allergan, Inc. (AGN.N) $98.54 +0.09
Novartis AG (NOVN.VX) CHF72.40 +0.65
Alnylam Pharmaceuticals, Inc. (ALNY.OQ) $27.56 +0.12
Regeneron Pharmaceuticals Inc (REGN.OQ) $259.96 -3.68
QLT Inc. (QLT.TO) $8.11 +0.01
Merck & Co., Inc. (MRK.N) $47.33 +2.12

Earnings vs. Estimates

Search Stocks